Cogent Biosciences (COGT) Preferred Dividend Payments (2017 - 2018)
Cogent Biosciences (COGT) posted quarterly Preferred Dividend Payments of $16000.0 for Q1 2018, little changed year-over-year from $16000.0 in Q1 2017, and little changed quarter-over-quarter from $16000.0 in Q4 2017.
Powered by 
Analysis
Cogent Biosciences (COGT) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Cogent Biosciences (COGT) has reported Preferred Dividend Payments for 2 consecutive years, with $16000.0 the latest figure, recorded in Q1 2018.
- In Q1 2018, Preferred Dividend Payments changed 0.0% year-over-year to $16000.0; the TTM figure through Dec 2018 stood at $16000.0 (down 75.38% YoY), while the FY2018 annual figure was $16000.0, down 75.38% from the prior year.
- Preferred Dividend Payments steadied at $16000.0 in Q1 2018 per COGT's latest filing, from $16000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $17000.0 in Q2 2017 and bottomed at $16000.0 in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Cogent Biosciences | 5.95 Bn | 5.95 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 16,000.00 |
| Dec 31, 2017 | 16,000.00 |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 17,000.00 |
| Mar 31, 2017 | 16,000.00 |